Effects of Combined Psychological and Functional Exercise Interventions on Emotion, Life Quality, and Brain-Derived Neurotrophic Factor Levels in Patients With Parkinson's Disease: A Randomized Controlled Trial.

Int J Psychiatry MedJan 29, 2026 (epub)
Clinical ResearchNeurologyPsychiatry

Tao Ding, Jing Zhang, Xue Jiang et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial evaluated a 12-week programme combining psychological support and functional exercise, added to routine care, in 172 patients with Parkinson’s disease. Compared with routine care alone, the intervention group had significantly lower anxiety, depression, PDQ-39, and MDS-UPDRS scores, and higher Barthel Index scores and serum BDNF levels (P < 0.001). Adherence was also higher with the combined programme: 90.70% vs 76.74% (P = 0.01). The findings suggest benefits across emotional, quality-of-life, functional, and biomarker outcomes over the intervention period.

Key findings

  • At 12 weeks, anxiety, depression, PDQ-39, and MDS-UPDRS scores were significantly lower in the intervention group than in controls (P < 0.001).
  • Barthel Index scores and serum BDNF levels were higher with the combined intervention than with routine care (P < 0.001).
  • Adherence was 90.70% in the intervention group versus 76.74% in the control group (P = 0.01).

Why it matters

The trial reports that a combined psychological and functional exercise programme was associated with improvements across several patient-relevant domains, alongside higher adherence. Considering emotional symptoms, daily functioning, and quality of life together may be useful when evaluating supportive interventions for Parkinson’s disease. The BDNF result is a biomarker finding and should be interpreted separately from the reported clinical outcomes.

What to keep in mind

Outcomes were assessed before and after a 12-week intervention; the abstract does not report longer-term follow-up or the magnitude of between-group differences.

Source

Published in Int J Psychiatry Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Neurology

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.